1. Emerging viruses remain a threat to health globally and they can not be readily eradicated as their natural reservoir is wild animals.
2. The threat posed mostly comes from known viruses that re-emerge intermittently or emerge in countries where the population has not been exposed before.
However, viruses that have never been reported before can also appear.
3. Individuals should seek health advice before overseas travel.
4. Clinicians need to ask about travel history and know the local pathway/arrangements for managing imported fever.
5. Public health surveillance and response is interlinked with the clinical response.
Research and development is needed for vaccines, treatments and diagnostics
to minimise the risk of infection and the size of outbreaks.
What is on the radar, why and what is the potential impact?
The outbreak of severe acute respiratory syndrome coronavirus (SARS-CoV) Emerging viruses are going to be a continuing threat for a number of reasons. A growing global population and urban spread means that more people are living in closer proximity to the natural reservoirs of these viruses and each other. Greater mobility and connectivity allows these infections to spread more rapidly across the globe (Weiss & McMichael 2004) . As bat species are the reservoirs for a number of these viruses it would be very difficult, if not impossible, eradicate the viruses from these hosts and stop the initial spillover events (Amman et al. 2014 ).
The scale of the Ebola outbreak in West Africa has been widely cited as unprecedented.
The number of cases exceeded 28 000 while the previous largest outbreak, in Uganda in 2000-2001, had just 425 cases . These figures are unfortunately dwarfed by the estimated impact of emerging viruses over the last century -1918 pandemic influenza killed 50-100 million people (Johnson & Mueller 2002) , and HIV has claimed over 35 million lives (World Health Organisation 2016). The SARS-CoV outbreak cost an estimated USD$40bn. Lastly, pandemics in the 21 st century are predicted to wipe USD$6tn off the global economy (Anon 2016 ).
In the UK, the number of cases underestimates the impact of emerging viruses as extensive efforts and resources are expended to prevent spread.
Mitigating the threat
Strategies for reducing the risk of outbreaks of emerging viruses occurring and the size of any outbreaks are well known: surveillance, early diagnosis, infection control/isolation, clinical care, contact tracing and community mobilisation.
Surveillance
Within the UK, the multi-agency Human Animal Infections and Risk Surveillance (HAIRS) group undertakes horizon scanning (HAIRS 2013) to identify, discuss and risk assess infections with potential for interspecies transfer (i.e. zoonotic infections).
HAIRS publishes a monthly report of infections thought to be of potential significance (Table 2) as well as disease specific risk assessments, most recently for Zika (HAIRS 2016).
Pre-travel NaTHNaC, the National Travel Health Network and Centre, provides travel health advice and guidance for healthcare professionals and travellers (Table 2) .
Control
The high quality of UK infrastructure (water, sanitation, housing etc.), high standards of living, climate and universal infection control precautions within healthcare offers some protection against spread of infectious diseases in the UK. This is highly effective for many imported infections (cholera, rabies virus, malaria etc.). However specific diseases require additional control measures.
On return from overseas travel, an early specific response is dependent on early recognition and thus clinicians asking about travel history is key. This was reinforced recently as part of both Ebola and Zika responses.
Once the risk of an imported infection is identified, the initial support for clinicians comes from local infection services (microbiology, virology or infectious disease teams). Local health economies will have established systems for managing infectious diseases. 
Public health and scientific research
The public health and clinical responses should be implemented hand in hand with scientific research and development programmes. These would include fundamental research to improve our understanding of these viruses, disease specific interventions and also technological platforms that could be used to target a variety of different viruses. Ongoing endeavours include:
1. Ensuring a more integrated global framework of public health bodies to counter infectious diseases. These would comprise strong national public health infrastructure that could be advised by effective global and regional bodies.
Implementation of the International Health Regulations (Anon 2005) , and the Global Health Security Agenda (Table 2) will both contribute to this. The combined cost for all of this? An estimated USD$4.5bn a year (Anon 2016 ). This sounds a lot, but needs to be balanced against the USD$40bn cost of SARS-CoV alone (Anon 2016) . 
